Twinaqt

🧾 Product Overview Table

🧪 Introduction: Treating HIV with Dual Therapy

Twinaqt combines two powerful antiretrovirals—Dolutegravir and Lamivudine—to effectively treat HIV-1 infection in adults and adolescents over 12 years of age. This fixed-dose combination is a simplified regimen designed for those without prior antiretroviral therapy resistance. It aligns with WHO recommendations for optimized dual-drug therapy in select patient populations.

Emcure Pharmaceuticals Ltd., a pioneer in affordable antiretroviral medicines, manufactures Twinaqt under stringent international quality standards. Its formulation aims to reduce pill burden while maintaining long-term viral suppression.

🎥 Educational Video

👩‍⚕️ Expert Commentary: Dr. Manish Verma, Infectious Disease Specialist

“Twinaqt is an excellent choice for first-line HIV treatment in patients without resistance mutations. With only two active ingredients, it simplifies dosing and improves adherence without compromising efficacy.”

💉 Dosage & Usage

• Swallow whole with or without food.
• Do not crush or chew.

⚠️ Side Effects, Storage & Warnings

• Common Side Effects: Headache, fatigue, nausea, insomnia
• Serious Effects: Liver dysfunction, allergic reactions, depressive episodes
• Storage: Store at room temperature, away from moisture
• Warnings:
  • Not for patients with hepatitis B unless combined with HBV-active drugs
  • Use caution in individuals with psychiatric history

🌍 Global Availability & Shipping Info

🔗 Related Indian Alternatives (Different Molecules in Same Category)

📖 External References

• FDA: Dolutegravir + Lamivudine
• WHO HIV Guidelines
• Drugs.com – Dovato Info
• NHS HIV Treatments

🚑 Medical Disclaimer

This article is for informational purposes only. Always consult a licensed healthcare provider before beginning or modifying HIV treatment.